AAAAAA
Results:
1-7
|
Results: 7
Authors:
Agertoft, L
Pedersen, S
Citation: L. Agertoft et S. Pedersen, Asthma, corticosteroids, and growth., N ENG J MED, 344(8), 2001, pp. 608-608
Authors:
Nikander, K
Agertoft, L
Pedersen, S
Citation: K. Nikander et al., Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide, J ASTHMA, 37(5), 2000, pp. 451-459
Authors:
Agertoft, L
Pedersen, S
Citation: L. Agertoft et S. Pedersen, Effect of long-term treatment with inhaled budesonide on adult height in children with asthma, N ENG J MED, 343(15), 2000, pp. 1064-1069
Authors:
Agertoft, L
Pedersen, S
Nikander, K
Citation: L. Agertoft et al., Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma, J AEROSOL M, 12(3), 1999, pp. 161-169
Authors:
Agertoft, L
Pedersen, S
Citation: L. Agertoft et S. Pedersen, Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide, J ALLERG CL, 104(5), 1999, pp. 948-952
Authors:
Verder, H
Albertsen, P
Ebbesen, F
Greisen, G
Robertson, B
Bertelsen, A
Agertoft, L
Djernes, B
Nathan, E
Reinholdt, J
Citation: H. Verder et al., Nasal continuous positive airway pressure and early surfactant therapy forrespiratory distress syndrome in newborns of less than 30 weeks' gestation, PEDIATRICS, 103(2), 1999, pp. E241-E246
Authors:
Agertoft, L
Andersen, A
Weibull, E
Pedersen, S
Citation: L. Agertoft et al., Systemic availability and pharmacokinetics of nebulised budesonide in preschool children, ARCH DIS CH, 80(3), 1999, pp. 241-247
Risultati:
1-7
|